IBDEI0XP ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16638,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,16638,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,16638,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,16639,0)
 ;;=V10.43^^92^940^69
 ;;^UTILITY(U,$J,358.3,16639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16639,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,16639,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,16639,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,16640,0)
 ;;=V10.46^^92^940^70
 ;;^UTILITY(U,$J,358.3,16640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16640,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,16640,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,16640,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,16641,0)
 ;;=V10.06^^92^940^71
 ;;^UTILITY(U,$J,358.3,16641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16641,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,16641,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,16641,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,16642,0)
 ;;=V10.52^^92^940^72
 ;;^UTILITY(U,$J,358.3,16642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16642,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,16642,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,16642,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,16643,0)
 ;;=V10.04^^92^940^74
 ;;^UTILITY(U,$J,358.3,16643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16643,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,16643,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,16643,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,16644,0)
 ;;=V10.47^^92^940^75
 ;;^UTILITY(U,$J,358.3,16644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16644,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,16644,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,16644,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,16645,0)
 ;;=V10.83^^92^940^73
 ;;^UTILITY(U,$J,358.3,16645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16645,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,16645,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,16645,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,16646,0)
 ;;=285.22^^92^940^9
 ;;^UTILITY(U,$J,358.3,16646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16646,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,16646,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,16646,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,16647,0)
 ;;=285.21^^92^940^10
 ;;^UTILITY(U,$J,358.3,16647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16647,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,16647,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,16647,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,16648,0)
 ;;=285.29^^92^940^11
 ;;^UTILITY(U,$J,358.3,16648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16648,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,16648,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,16648,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,16649,0)
 ;;=284.9^^92^940^12
 ;;^UTILITY(U,$J,358.3,16649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16649,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,16649,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,16649,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,16650,0)
 ;;=282.61^^92^940^78
 ;;^UTILITY(U,$J,358.3,16650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16650,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,16650,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,16650,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,16651,0)
 ;;=282.7^^92^940^77
 ;;^UTILITY(U,$J,358.3,16651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16651,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,16651,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,16651,2)
 ;;=^87629
